← Leaderboards
Stavroula Kousteni
Columbia University Health Sciences
$21,735,971
Attributed
$22,720,941
Total exposure
15
Grants
15
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $6.2M · FY2007–25$10M$7.5M$5M$2.5M$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$28,243,167 · 16
By mechanism
P01$13,791,910 · 6
R01$12,600,528 · 7
T32$1,162,229 · 1
R56$688,500 · 2
Top collaborators
- Raul Rabadan4 shared
Most similar at Columbia University Health Sciences
Same institution · by research overlap
- Marcella Donovan Walker$7,395,907
- Michael T Yin$11,180,339
- Emily Margaret Stein$1,414,057
- Adi Cohen$3,447,742
- Ronald Wapner$40,934,262
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsOsteoblastsSignal TransductionBone MarrowMolecularAffectLeadMediatingAgingSignal PathwayBonePathway InteractionsEventMutationRegulationGeneticIn VitroProgenitorHematopoietic Stem CellsDysmyelopoietic SyndromesIn VivoHematopoieticProteinsHematopoiesis
Grant awards (56)
Aging-related hematopoietic stem cell intrinsic and microenvironmental signals in AML transformation$2,747,089
P01 · FY2025 · CA · contact PI
Regulation of hematopoietic regeneration in the aging marrow by bone$638,393
P01 · FY2025 · AG · contact PI
Project 3: Role of stromal cell-activated CNOT6L deadenylase in driving AML transformation$628,854
P01 · FY2025 · CA · contact PI
Epigenetic deregulation of osteoblasts promotes age related clonality in hematopoietic cellsÂ$616,113
R01 · FY2025 · AG · contact PI
Core A: Administrative Core$506,089
P01 · FY2025 · CA · contact PI
Molecular Mechanisms of MDS pathogenesis with aging$490,000
R01 · FY2025 · AG · contact PI
Cellular and Molecular mechanisms of ATRA inhibition of osteoblast-induced MDS development$301,514
R01 · FY2025 · AR · contact PI
Hormones: Molecular Mechanism of Action and Functions$269,505
T32 · FY2025 · DK · contact PI
Aging-related hematopoietic stem cell intrinsic and microenvironmental signals in AML transformation$2,775,137
P01 · FY2024 · CA · contact PI
Epigenetic deregulation of osteoblasts promotes age related clonality in hematopoietic cellsÂ$719,873
R01 · FY2024 · AG · contact PI
Project 3: Role of stromal cell-activated CNOT6L deadenylase in driving AML transformation$594,718
P01 · FY2024 · CA · contact PI
Bone as a regulator and responder to acute inflammation throughout life$551,286
P01 · FY2024 · AG · contact PI
Core A: Administrative Core$515,274
P01 · FY2024 · CA · contact PI
Molecular Mechanisms of MDS pathogenesis with aging$500,000
R01 · FY2024 · AG · contact PI
Cellular and Molecular mechanisms of ATRA inhibition of osteoblast-induced MDS development$324,966
R01 · FY2024 · AR · contact PI
Hormones: Molecular Mechanism of Action and Functions$225,297
T32 · FY2024 · DK · contact PI
Bone as a regulator and responder to acute inflammation throughout life$551,286
P01 · FY2023 · AG · contact PI
Molecular Mechanisms of MDS pathogenesis with aging$500,000
R01 · FY2023 · AG · contact PI
Cellular and Molecular mechanisms of ATRA inhibition of osteoblast-induced MDS development$335,016
R01 · FY2023 · AR · contact PI
Hormones: Molecular Mechanism of Action and Functions$219,872
T32 · FY2023 · DK · contact PI
Bone as a regulator and responder to acute inflammation throughout life$551,286
P01 · FY2022 · AG · contact PI
Cellular and Molecular mechanisms of ATRA inhibition of osteoblast-induced MDS development$331,666
R01 · FY2022 · AR · contact PI
Hormones: Molecular Mechanism of Action and Functions$231,961
T32 · FY2022 · DK · contact PI
Bone as a regulator and responder to acute inflammation throughout life$551,286
P01 · FY2021 · AG · contact PI
Cellular and Molecular mechanisms of ATRA inhibition of osteoblast-induced MDS development$335,016
R01 · FY2021 · AR · contact PI
Role of epigenetic alterations in the bone marrow niche to aging-related hematopoietic clonality leading to IDH mutant MDS and AML$332,100
R56 · FY2021 · AG · contact PI
Hormones: Molecular Mechanism of Action and Functions$215,594
T32 · FY2021 · DK · contact PI
Bone as a regulator and responder to acute inflammation throughout life$551,286
P01 · FY2020 · AG · contact PI
Neuronal control of bone mass by Sirt1$514,440
P01 · FY2019 · AG · contact PI
Genetic characterization of osteoblast-induced leukemias$461,485
R01 · FY2019 · HL · contact PI
Molecular basis of the inhibitory effects of ATRA on osteoblast-induced MDS/AML$356,400
R56 · FY2019 · AR · contact PI
Neuronal control of bone mass by Sirt1$517,064
P01 · FY2018 · AG · contact PI
Genetic characterization of osteoblast-induced leukemias$461,485
R01 · FY2018 · HL · contact PI
Neuronal control of bone mass by Sirt1$527,558
P01 · FY2017 · AG · contact PI
Genetic characterization of osteoblast-induced leukemias$461,485
R01 · FY2017 · HL · contact PI
The Osteoblast as a Determinant of Leukemogenesis$341,711
R01 · FY2017 · AR · contact PI
Genetic characterization of osteoblast-induced leukemias$585,485
R01 · FY2016 · HL · contact PI
Neuronal control of bone mass by Sirt1$532,808
P01 · FY2016 · AG · contact PI
The Osteoblast as a Determinant of Leukemogenesis$341,711
R01 · FY2016 · AR · contact PI
Neuronal control of bone mass by Sirt1$538,056
P01 · FY2015 · AG · contact PI
The Osteoblast as a Determinant of Leukemogenesis$341,711
R01 · FY2015 · AR · contact PI
The Osteoblast as a Determinant of Leukemogenesis$345,904
R01 · FY2014 · AR · contact PI
The Osteoblast as a Determinant of Leukemogenesis$352,518
R01 · FY2013 · AR · contact PI
Sirtuin/FOXO Signaling in the Regulation of Bone Mass$335,168
R01 · FY2012 · AR · contact PI
HORMONAL CONTROL OF PERIOSTEAL EXPANSION$302,968
R01 · FY2012 · AR · contact PI
Sirtuin/FOXO Signaling in the Regulation of Bone Mass$335,168
R01 · FY2011 · AR · contact PI
HORMONAL CONTROL OF PERIOSTEAL EXPANSION$302,968
R01 · FY2011 · AR · contact PI
Sirtuin/FOXO Signaling in the Regulation of Bone Mass$349,133
R01 · FY2010 · AR · contact PI
HORMONAL CONTROL OF PERIOSTEAL EXPANSION$315,592
R01 · FY2010 · AR · contact PI
Sirtuin/FOXO Signaling in the Regulation of Bone Mass$642,833
R01 · FY2009 · AR · contact PI
Sirtuin/FOXO Signaling in the Regulation of Bone Mass$352,660
R01 · FY2009 · AR · contact PI
HORMONAL CONTROL OF PERIOSTEAL EXPANSION$318,780
R01 · FY2009 · AR · contact PI
Sirtuin/FOXO Signaling in the Regulation of Bone Mass$352,660
R01 · FY2008 · AR · contact PI
HORMONAL CONTROL OF PERIOSTEAL EXPANSION$318,780
R01 · FY2008 · AR · contact PI
OSTEOBLAST COMMITMENT AND DIFFERENTIATION BY ANGELS$256,855
R01 · FY2008 · AR · contact PI
OSTEOBLAST COMMITMENT AND DIFFERENTIATION BY ANGELS$269,304
R01 · FY2007 · AR · contact PI